Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 60 /hr
Hire Dr. Elsa S.
Portugal
USD 60 /hr
PhD in Stem Cell Biology | 8+ years of research experience | 3+ years of drug discovery experience in industry
Profile Summary
Subject Matter Expertise
Services
Writing
Technical Writing,
General Proofreading & Editing
Research
Gray Literature Search,
Scientific and Technical Research,
Systematic Literature Review
Consulting
Scientific and Technical Consulting
Data & AI
Statistical Analysis
Work Experience
Business Developer
FairJourney Biologics
June 2022 - November 2022
Client Manager
Charles River Laboratories
July 2021 - May 2022
Senior Scientist/Scientist
Charles River Laboratories
May 2019 - June 2021
Postdoctoral Research Associate
University of Cambridge
September 2018 - April 2019
PhD candidate
University of Cambridge
October 2014 - August 2018
Education
PhD in Developmental and Stem Cell Biology
University of Cambridge / University of Porto
January 2014 - August 2018
MSc in Molecular Oncology
University of Porto
September 2010 - November 2012
BSc in Biology
University of Porto
September 2007 - June 2010
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
et al., Hannah T. Stuart, Giuliano G. Stirparo, Tim Lohoff, Lawrence E. Bates, Masaki Kinoshita, Chee Y. Lim, Elsa J. Sousa, Katsiaryna Maskalenka, Aliaksandra Radzisheuskaya, Andrew A. Malcolm(2019). Distinct Molecular Trajectories Converge to Induce Naive Pluripotency . Cell Stem Cell. 25. (3). p. 388--406.e8. Elsevier {BV}
Elsa J. Sousa, Hannah T. Stuart, Lawrence E. Bates, Mohammadmersad Ghorbani, Jennifer Nichols, Sabine Dietmann, José C.R. Silva(2018). Exit from Naive Pluripotency Induces a Transient X Chromosome Inactivation-like State in Males . Cell Stem Cell. 22. (6). p. 919--928.e6. Elsevier {BV}
Daniela Barros-Silva, Pedro Costa-Pinheiro, Henrique O. Duarte, Elsa Joana Sousa, Adriane Feijó Evangelista, Inês Graça, Isa Carneiro, Ana Teresa Martins, Jorge Oliveira, André L. Carvalho, et al.(2018). MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis . Cell Death & Disease. 9. (2). Springer Science and Business Media {LLC}
Filipa Quintela Vieira, Pedro Costa-Pinheiro, Diogo Almeida-Rios, Inês Graça, Sara Monteiro-Reis, Susana Simões-Sousa, Isa Carneiro, Elsa Joana Sousa, Maria Inês Godinho, Fátima Baltazar, et al.(2015). SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3 . Oncotarget. 6. (15). p. 13644--13657. Impact Journals, {LLC}
Inês Graça, Elsa J Sousa, Pedro Costa-Pinheiro, Filipa Q Vieira, Jorge Torres-Ferreira, Maria Gabriela Martins, Rui Henrique, Carmen Jerónimo(2014). Anti-neoplastic properties of hydralazine in prostate cancer . Oncotarget. 5. (15). p. 5950--5964. Impact Journals, {LLC}
Elsa Sousa, Ines Graca, Tiago Baptista, Mafalda Almeida, Joao Ramalho-Carvalho, Carlos Palmeira, Rui Henrique, Carmen Jeronimo(2014). Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells . Current Pharmaceutical Design. 20. (11). p. 1803--1811. Bentham Science Publishers Ltd.
Tiago Baptista, Inês Graça, Elsa J. Sousa, Ana I. Oliveira, Natália R. Costa, Pedro Costa-Pinheiro, Francisco Amado, Rui Henrique, Carmen Jerónimo(2013). Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer . Oncotarget. 4. (10). p. 1673--1685. Impact Journals, {LLC}
Elsa J. Sousa, Inês Graça, Tiago Baptista, Filipa Q. Vieira, Carlos Palmeira, Rui Henrique, Carmen Jerónimo(2013). Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing . Epigenetics. 8. (5). p. 548--558. Informa {UK} Limited